Friday, July 31, 2026

ABL209: The Promising Dual Antibody ADC Revolutionizing Cancer Treatment in 2026

ABL Bio's ABL209 shows promising anti-cancer effects with broad safety in preclinical studies, advancing to Phase 1 trials in the U.S.

Kim, Xi, and Putin Unite at Beijing Parade in Rare Display of Power

Kim Jong Un's visit to China for Victory Day highlights potential North Korea-China-Russia alliance amid cautious Chinese diplomacy.

North Korea Criticizes South Korea for ‘2.3 Million Tons of CO₂’ Emissions

North Korea addresses South Korea's wildfire crisis, highlighting significant CO₂ emissions and issuing a wildfire risk alert for the region.

Tag: Growth

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

China’s 5-Minute EV Charging Revolution: How BYD’s Technology Leaves the U.S. Behind

China leads in EV charging tech with 70% charge in 5 mins, while the U.S. boosts infrastructure amid sales challenges.

Estipam Secures Record 897 Billion KRW Contract for Oligonucleotide Raw Materials: What This Means for the Asian Market

ST Pharm secures a record 89.7 billion KRW contract for oligonucleotide ingredients, enhancing its global market position.

Dongkoo Bio&Pharma Invests 1 Billion KRW in GenomAndCompany: What This Means for ADC Drug Development

Dongkoo Bio&Pharma invests 1 billion KRW in Genome & Company to enhance antibody and ADC drug development strategies.

Ubicare Targets 80%+ Operating Profit Growth in 2026 — Here’s What’s Changing in Its EMR and Platform Play

Ubicare reported a 46% increase in operating profit for 2025, driven by optimized revenue structures and plans for AI solutions in 2026.

U.S. Buyers Push Hyundai’s Electrified Line to New Record

Hyundai Motor's eco-friendly vehicle sales in the U.S. surpass 1 million, led by hybrids, showing rapid growth in recent years.

Made in America Dialysis Tech Gains Ground as Patient Numbers Surge

The number of dialysis patients in South Korea has nearly doubled in the past decade, with about 130,000 expected by 2025.

A New Hair-Growth Pathway?: JW0061 Targets GFRA1 After 7.2x Organoid Results and a 39% Animal Boost

JW Pharmaceutical's hair loss treatment JW0061 gains FDA approval for clinical trials, promising innovative growth stimulation for men and women.

Hugel’s Record-Breaking 2025 Financials: How Botulax and HA Fillers Drive 14% Revenue Growth

Hugel reports record 2025 financials with strong sales in toxins, fillers, and cosmetics, focusing on global market expansion.

SK Biopharm’s 2026 Sales Meeting: Key Strategies for Senolamate’s Global Success

SK Biopharm's U.S. subsidiary held its annual sales meeting, focusing on growth strategies and collaboration for Cenobamate's success.

ST Pharm’s Record Growth: How RNA-Based Therapies Are Transforming the CDMO Market in 2026

ST Pharm reports record growth in oligonucleotide CDMO, driven by rising demand for RNA-based treatments for chronic diseases.

Wontek’s V-Laser Approved for Versatile Treatments in Vietnam: A Game-Changer for Aesthetic Clinics

Wontech secures medical device approval for its V-Laser in Vietnam, enhancing its product lineup and market presence in medical aesthetics.

Elanco’s Vision for 2030: Key Insights from CEO Jeffrey Simmons’ Visit to South Korea

Elanco CEO Jeffrey Simmons visited South Korea to discuss growth strategies, celebrate anniversaries, and emphasize employee partnership.

K-Beauty Boom: How Classys, Hugel, and Wontech are Expanding in Global Markets

The K-beauty industry is growing, leveraging strong manufacturing and R&D capabilities alongside the global spread of Hallyu.

Celltrion Gets Global IB Upgrades: Morgan Stanley Raises Target to $206.25 as New Biosimilars Lift Margins

Celltrion is expanding through biosimilars and new drug development, attracting global investor interest and raising target stock prices.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.